Jacques Rossignol is a Managing Partner and Co-Founder of TechLife Capital.
He has been a private equity growth investor for 18 years, completing 9 investments and 12 build-ups. He has covered the healthcare industry for 17 years and the technology industry for 23 years. Before TechLife Capital, he was head of France at Alpha Private Equity, Managing Partner at 21 Invest and Director at Ekkio.
Jacques is currently the President of the Supervisory Board of XPath Groupe (cancer diagnosis services), and of Flash Therapeutics (manufacturer of lentiviral vectors for biotech companies).
His previous Supervisory Board positions include Synerlab (manufacturer of pharmaceutical drugs) and Digital Virgo (mobile internet services).
He started his career in Investment Banking at BNP Paribas and Goldman Sachs (Paris, London).
Jacques is a graduate from Ecole Polytechnique and holds an MBA degree from the Harvard Business School.